Featured Content

Update on Pharmacotherapeutic Options for Rheumatoid Arthritis 10/18/2013

The chronic systemic inflammatory response associated with rheumatoid arthritis affects most joints and their surrounding tissues.

Related Content

Atypical Antipsychotics: Safety and Use in Pediatric Patients

Second-generation antipsychotics are first-line agents for children and adolescents.



Management of Adolescent Obesity

The cause of adolescent obesity is regarded as multifaceted, given the numerous components that increase a child’s risk of developing the condition.

The Enterovirus D68 Outbreak: A Public Health Concern

Pediatric patients with preexisting respiratory conditions are at the greatest risk of infection.



Antimicrobial Therapy for Community-Acquired Pneumonia

Antibiotic resistance and the risk of fatal adverse events make it challenging to select an agent.

Advice for Patients With Tremor

Self-help techniques may provide some relief from symptoms such as shaking.



FDA Approves First New Lupus Therapy in Over 50 Years 4/20/2011



An Overview of Systemic Lupus Erythematosus 9/20/2010

Additional research and new treatments for lupus are critically needed.


Dermatologic Signs of Rheumatoid Arthritis 4/20/2009

Rheumatoid arthritis, the most common inflammatory arthritis, is a chronic autoimmune disease and an important cause of disability in seniors.

Drug–Drug Interactions with HIV Antiretroviral Therapy 4/18/2008

Drug-drug interactions are often a serious complication of taking multiple medications and account for 3% to 5% of all in-hospital medication errors.

The Antiphospholipid Syndrome 1/23/2008

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiphospholipid antibodies, manifesting with vascular thrombosis and/or recurrent fetal loss.

Sjögren’s Syndrome 3/21/2007

Sjögren's (SHOW-grins) syndrome is an autoimmune disease that attacks the exocrine glands (i.

Advertisement